MRK vs CI
By Alex · Tickerpine
Merck & Co., Inc. vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | CI |
|---|---|---|
| Price | $128.66 | $282.79 |
| Market cap | $317.77B | $74.81B |
| P/E ratio | 36.2 | 12.0 |
| ROE | 18.94% | 16.27% |
| Profit margin | 13.59% | 2.26% |
| Revenue growth | 4.90% | 4.60% |
| Dividend yield | 2.64% | 2.21% |
| Beta | 0.22 | 0.30 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs CI in plain English
- MRK is the bigger company — about 4.2× the market cap of CI.
- CI is cheaper on earnings (P/E 12.0 vs 36.2).
- MRK earns a higher return on equity (19% vs 16%).
- MRK is growing revenue faster (5% vs 5%).
- MRK has the higher dividend yield (2.64% vs 2.21%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.